Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease

被引:0
|
作者
郑克勤
张思仲
贺勇
张立
张克兰
黄德嘉
孙岩
机构
[1] Department of Medical Genetics,West China Hospital
[2] Key Laboratory for Forensic Genomics and Forensic Medicine of Sichuan Province
[3] Division of Human Forensic Genomics, Key Laboratory for Biotherapy of Human Diseases of the Ministry of Education,Sichuan University,Chengdu 610041,China ,Department of Cardiology, West China Hospital, Sichuan University,Chengdu 610041, China ,Department o
[4] Division of Human Forensic Genomics, Key Laboratory for Biotherapy of Human Diseases of the Ministry of Education,Sichuan University,Chengdu 610041,China ,Department of Medical Genetics,West China Hospital
[5] Division of Human Forensic Genomics, Key Laboratory for Biotherapy of Human Diseases of the Ministry of Education,Sichuan University,Chengdu 610041,China ,Department of Cardiology, West China Hospital, Sichuan University,Chengdu 610041, China ,Department o
关键词
cholesteryl ester transfer protein · gene polymorphism · coronary heart disease · plasma lipids;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
Background The TaqⅠB, MspⅠ and I405V polymorphisms of cholesteryl ester transfer protein (CETP), an important regulatory factor of lipid metabolism, have been attracted much more attention by the researchers. In this study, we investigated the associations between these 3 polymorphisms of CETP gene and variations in plasma lipid and lipoprotein levels in patients with coronary heart disease (CHD).Methods Genomic DNA was extracted from leukocytes of 203 CHD patients and 100 control subjects using the salting out method. Genotyping of the CETP gene was performed using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. Statistical analysis was conducted using the SPSS 10.0 software package.Results The distribution of allele and genotype frequencies of the TaqⅠB, MspⅠ, and I405V polymorphisms was similar in the CHD patient group and the control group. The B1B1 genotype of the TaqⅠB polymorphism was associated with significantly higher TC (P=0.039) and LDL-C (P=0.044) levels than the B2B2 genotype in CHD patients, and with significantly higher LDL-C (P=0.034) levels than the B2B2 genotype in controls. Homozygotes of the I405V polymorphism exhibited significantly higher HDL-C levels than VV homozygotes among control subjects (P=0.023). In male CHD patients with unambiguously assigned haplotypes, B2-M2-V/B2-M2-I patients demonstrated significantly higher HDL-C concentrations than B1-M2-V/B1-M2-I (P=0.023) and B1-M2-V/B1-M2-V patients (P=0.047). Conclusions Genetic variations in the CETP gene may account for a significant proportion of the differences in plasma lipid and lipoprotein concentrations among the general population. The B1B1 genotype of the TaqⅠB polymorphism is probably a genetic risk factor for CHD in the study population.
引用
收藏
页码:8 / 12
页数:5
相关论文
共 50 条
  • [31] The interaction of cholesteryl ester transfer protein gene variations and diet on changes in serum lipid profiles
    Firoozeh Hosseini-Esfahani
    Zohre Esfandiar
    Parvin Mirmiran
    Maryam S. Daneshpour
    Arash Ghanbarian
    Fereidoun Azizi
    European Journal of Clinical Nutrition, 2019, 73 : 1291 - 1298
  • [32] The interaction of cholesteryl ester transfer protein gene variations and diet on changes in serum lipid profiles
    Hosseini-Esfahani, Firoozeh
    Esfandiar, Zohre
    Mirmiran, Parvin
    Daneshpour, Maryam S.
    Ghanbarian, Arash
    Azizi, Fereidoun
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2019, 73 (09) : 1291 - 1298
  • [33] Association between the TaqIB polymorphism of the cholesteryl ester transfer protein gene and postprandial triglyceride levels in patients with familial hypercholesterolemia.
    Kolovou, Genovefa
    Anagnostopoulou, Katherine
    Salpea, Klelia
    Hatzigeorgiou, George
    Marvaki, Christina
    Mihas, Constantinos
    Degiannis, Dimitris
    Mikhailidis, Dimitri
    Cokkinos, Dennis V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 325A - 325A
  • [34] Association between cholesteryl ester transfer protein activity and coronary artery disease complication in Tunisian patients with type 2 diabetes
    Hammami, M
    Chaaba, R
    Hammami, S
    Attia, N
    Mahjoub, S
    Smaoui, M
    Ben Hamd, K
    Ben Farhat, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 39 - 39
  • [35] Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk
    Barter, Philip J.
    Rye, Kerry-Anne
    CARDIOLOGY CLINICS, 2018, 36 (02) : 299 - +
  • [36] Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease
    Zhu, HY
    Gopalraj, RK
    Kelly, JF
    Bennett, DA
    Estus, S
    NEUROSCIENCE LETTERS, 2005, 381 (1-2) : 36 - 41
  • [37] Association of Cholesteryl Ester Transfer Protein and Endothelial Nitric Oxide Synthase Gene Polymorphisms With Coronary Artery Disease in the Multi-Ethnic Malaysian Population
    Chu, Wern Cui
    Aziz, Ahmad Fazli Abdul
    Nordin, Abdul Jalil
    Cheah, Yoke Kqueen
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (06) : 581 - 588
  • [38] Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
    Zhong, SB
    Sharp, DS
    Grove, JS
    Bruce, C
    Yano, K
    Curb, JD
    Tall, AR
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12): : 2917 - 2923
  • [39] Association of cholesteryl ester transfer Protein-TaqIB polmorphyisms with HDL cholesterol levels and the risk of coronary artery disease
    Kotake, Hidetoshi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2007, 14 (03) : 152 - 153
  • [40] Polymorphisms of the cholesteryl ester transfer protein gene and severity of coronary stenosis estimated by Gensini and Jeopardy scores
    Kolovou, D
    Anagnostopoulou, K
    Kryofyllis, P
    Salpea, K
    Pilatis, N
    Yiannakouris, N
    Zarkalis, D
    Cokkinos, D
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 28 - 28